Cargando…
Stroke onset to needle delay: Where these golden hours are lost? An Egyptian center experience
BACKGROUND: The use of intravenous recombinant tissue plasminogen activator (IV r-tPA) in early acute ischemic stroke (AIS) management faces a lot of difficulties in developing countries due to lessened guideline development with consecutive pre- and intra-hospital delay. OBJECTIVES: The objective w...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330381/ https://www.ncbi.nlm.nih.gov/pubmed/30671551 http://dx.doi.org/10.1016/j.ensci.2019.01.003 |